Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Glenn, Salkeld"'
Publikováno v:
Health Expectations, Vol 25, Iss 6, Pp 2775-2785 (2022)
Abstract Background There are a range of treatment options for osteoarthritis (OA) of the knee and hip, each with a unique profile of risks and benefits. Patient decision aids can help incorporate patient preferences in treatment decision‐making. T
Externí odkaz:
https://doaj.org/article/05e60ac3161a4b60be8454b13a68be6c
Autor:
Jessica Orchard, Jialin Li, Ben Freedman, Ruth Webster, Glenn Salkeld, Charlotte Hespe, Robyn Gallagher, Anushka Patel, Bishoy Kamel, Lis Neubeck, Nicole Lowres
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 18 (2020)
BACKGROUND Internationally, most atrial fibrillation (AF) management guidelines recommend opportunistic screening for AF in people ≥65 years of age and oral anticoagulant treatment for those at high stroke risk (CHA₂DS₂‐VA≥2). However, gaps
Externí odkaz:
https://doaj.org/article/1694dba15a2e43868081838b17d89c59
Autor:
Lesley Chim, Glenn Salkeld, Patrick Kelly, Wendy Lipworth, Dyfrig A Hughes, Martin R Stockler
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172971 (2017)
BACKGROUND:Around the world government agencies responsible for the selection and reimbursement of prescribed medicines and other health technologies are considering how best to bring community preferences into their decision making. In particular, c
Externí odkaz:
https://doaj.org/article/3c3794e8b91442769fe6e6f3be8c6ebf
Autor:
Glenn Salkeld, Michelle Cunich, Jack Dowie, Kirsten Howard, Manish I Patel, Graham Mann, Wendy Lipworth
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152999 (2016)
IMPORTANCE:Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality. OBJE
Externí odkaz:
https://doaj.org/article/b1ca67e863e34d988a5b450878198b46
Autor:
Michael J. Solomon, Jane M. Young, Kilian G. M. Brown, Cherry E. Koh, Daniel Steffens, Glenn Salkeld
Publikováno v:
Annals of Surgery. 275:157-165
Objectives To determine what constitutes a clear resection margin (R0) in patients with LRRC. Summary of background data R0 is the most important predictor of survival in patients with LRRC. However, it is not clear what constitutes an R0. A 1-2 mm m
Publikováno v:
F1000Research, Vol 4 (2015)
Concern with the threshold applied in cost-effectiveness analyses by bodies such as NICE distracts attention from their biased use of the principle. The bias results from the prior requirement that an intervention be effective (usually 'clinically ef
Externí odkaz:
https://doaj.org/article/eef32e7b14c64344b654b0d823a1e543
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 27, Iss 4, Pp 449-455 (2003)
Abstract Objectives:To elicit community preferences for colorectal cancer (CRC) screening by faecal occult blood test (FOBT) using discrete choice modeling (DCM). To provide policymakers with information that would assist them in designing the future
Externí odkaz:
https://doaj.org/article/6c999d9a1db147d8af7f2705e60f709d
Autor:
Ian Flaherty, Sally Wortley, Glenn Salkeld, Hema Urban, Yun-Hee Jeon, David J. Hunter, Chris Dickson
Publikováno v:
Arthritis Care & Research. 71:46-55
Objective To qualitatively examine the experiences with, and impact of, evidence-based online resources in self-management among Australians with osteoarthritis. Methods Telephone interviews were conducted with 36 users of a novel osteoarthritis reso
Autor:
David Isaacs, Madlen Gazarian, Wendy Lipworth, Ian N. Olver, Narcyz Ghinea, Sallie Pearson, Christine Critchley, Bronwen Morrell, Terry Campbell, Winston Liauw, Glenn Salkeld, Ian Kerridge, Richard O. Day, Jessica Pace
Publikováno v:
Health Policy
Background In the past decade many novel, and in some cases transformative, cancer medicines have entered the market. Their prices and the amount spent on them by governments have increased rapidly, bringing to the forefront trade-offs that must be m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34f625e78ac2d9e8242279f6068e481
https://hdl.handle.net/2123/24903
https://hdl.handle.net/2123/24903
Autor:
Anushka Patel, Ben Freedman, Nicole Lowres, Ruth Webster, Bishoy Kamel, Robyn Gallagher, Glenn Salkeld, Charlotte Hespe, Jialin Li, Jessica Orchard, Lis Neubeck
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
BACKGROUND Internationally, most atrial fibrillation (AF) management guidelines recommend opportunistic screening for AF in people ≥65 years of age and oral anticoagulant treatment for those at high stroke risk (CHA₂DS₂‐VA≥2). However, gaps